With $250 million, Peter Diamandis’ new startup is all about taking stem cells from placentas

 Stem cells derived from a human placenta hold the key to unlocking a myriad of potentials in regenerative medicine and are the focus of X-Prize and Singularity University founder Peter Diamandis’ new endeavor. Called Celularity, the startup is a spinout from Celgene, a global biopharmaceutical company creating gene therapies. Diamandis teamed up with Dr. Robert Hariri, the founder of… Read More

http://ift.tt/2C20vVZ With $250 million, Peter Diamandis’ new startup is all about taking stem cells from placentas http://ift.tt/2BZev2r